Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4

10.1038/s41467-023-40829-2

Saved in:
Bibliographic Details
Main Authors: Kim, YN, Park, B, Kim, JW, Kim, BG, Kim, SW, Kim, HS, Choi, CH, Lim, MC, YL Ngoi, N, SP Tan, D, Lee, JY
Other Authors: MEDICINE
Format: Article
Published: Springer Science and Business Media LLC 2023
Subjects:
Humans
Female
Bevacizumab
Antibodies, Monoclonal, Humanized
Carcinoma, Ovarian Epithelial
Ovarian Neoplasms
Online Access:https://scholarbank.nus.edu.sg/handle/10635/245266
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

https://scholarbank.nus.edu.sg/handle/10635/245266

Similar Items